2019
DOI: 10.1016/j.hrthm.2019.05.015
|View full text |Cite
|
Sign up to set email alerts
|

Enhancement of β-catenin/T-cell factor 4 signaling causes susceptibility to cardiac arrhythmia by suppressing NaV1.5 expression in mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
8
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(8 citation statements)
references
References 25 publications
0
8
0
Order By: Relevance
“…Our laboratory and others have previously shown that developmental chronic β-catenin stabilization in mouse cardiomyocytes results in up-regulation of the Wnt signaling pathway and down-regulation of Scn5a , together with reduced Na V 1.5 protein and sodium current density. 17 , 18 , 22 Therefore, we asked whether adult-induced, chronically increased β-catenin in cardiomyocytes, which partially recapitulates GSK-3–mediated pharmacologic effects, is proarrhythmic. To determine whether cardiac conduction is regulated by β-catenin levels, we used a tamoxifen-inducible mouse model to conditionally delete β-catenin exon 3 in cardiomyocytes of adult mice ( αMHC-MCM +/o /Ctnnb1 fl(ex3)/+ , β-catenin GOF), which prevents β-catenin degradation through loss of phosphorylation sites targeting the protein for ubiquitination.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Our laboratory and others have previously shown that developmental chronic β-catenin stabilization in mouse cardiomyocytes results in up-regulation of the Wnt signaling pathway and down-regulation of Scn5a , together with reduced Na V 1.5 protein and sodium current density. 17 , 18 , 22 Therefore, we asked whether adult-induced, chronically increased β-catenin in cardiomyocytes, which partially recapitulates GSK-3–mediated pharmacologic effects, is proarrhythmic. To determine whether cardiac conduction is regulated by β-catenin levels, we used a tamoxifen-inducible mouse model to conditionally delete β-catenin exon 3 in cardiomyocytes of adult mice ( αMHC-MCM +/o /Ctnnb1 fl(ex3)/+ , β-catenin GOF), which prevents β-catenin degradation through loss of phosphorylation sites targeting the protein for ubiquitination.…”
Section: Resultsmentioning
confidence: 99%
“… 16 , 17 , 18 Specifically, both Scn5a , the gene encoding the major cardiac sodium-channel subunit Na V 1.5 (the pore-forming α-subunit protein of the voltage-gated cardiac sodium channel), and Gja1 , the gene encoding for cardiac gap junction connexin 43 (Cx43), are transcriptionally regulated by Wnt/β-catenin. 18 , 19 , 20 , 21 , 22 β-catenin is also involved in cell-cell adhesion at the adherens junctions, where it binds to N-cadherin. 23 , 24 It has been shown that β-catenin accumulates at the intercalated discs of hearts with hypertrophic cardiomyopathy and that GSK-3β is simultaneously decreased.…”
mentioning
confidence: 99%
“…Likewise in AF, the activation of this pathway may be contributing to the exacerbated oxidative damage. Recently, it was also observed that the transcription factor TCF/Lef activated by β-catenin negatively regulates the expression of the Nav1.5 sodium channel, encoded by the SCN5a gene, in addition to modulating its kinetics, promoting tachycardia and ventricular fibrillation in animal model (Huo et al 2019) . Regarding the structural remodeling of the atria, Wnt/β-catenin regulates the transcription of genes related to fibrosis in AF and in several other fibrotic diseases (Lv et al 2019) .…”
Section: Discussionmentioning
confidence: 99%
“…We discovered that that EGR1 was targeted by 53 TFs (ex; LMO2); DDX5 was targeted by 51 TFs (ex; MYCN); NCOA3 was targeted by 48 TFs (ex; SIN3B); STAT1 was targeted by 42 TFs (ex; IRF8); HIF1A was targeted by 40 TFs (ex; GATA1); RPS14 was targeted by 45 TFs (ex; RCOR3); RPL3 was targeted by 44 TFs (ex; DMRT1); RPS19 was targeted by 42 TFs (ex; GCH1 [81], LYST (lysosomal trafficking regulator) [82], PELI1 [83], EGR1 [84], SNX10 [85], CA2 [86], ZEB2 [87], HIF1A [88], PLA2G7 [89] [105], NFIA (nuclear factor I A) [106], CCR7 [107], PRDX2 [108], ADK (adenosine kinase) [109], TCF7 [110], LGALS3 [111], OLFM2 [112], HDAC11 [113] and ARPC1B [114] are significantly related to the atherosclerosis. Studies have revealed that KCNJ2 [115], TLR4 [116], JAK2 [117], TLR2 [118], EGR1 [119], GAB1 [120], ZBTB11 [121], BIN1 [122], TCF4 [123], PPP1R13L [124], TRPM4 [125], LGALS3 [126] and SNTA1 [127] plays a key role in cardiac arrhythmia. Recently, increasing evidence demonstrated that KCNJ2 [128], TLR4 [129], CYP2D6 [130], TLR2 [129], SNX10 [131], SIRT1 [132], PF4 [133], PCYT2 [134] and LGALS3 [135] were altered expression in atrial fibrillation.…”
Section: Construction Of the Tf-hub Gene Regulatory Networkmentioning
confidence: 99%